These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
331 related articles for article (PubMed ID: 8832309)
1. Quality of life before and during antihypertensive treatment: a comparative study of celiprolol and atenolol. Cleophas TJ; van der Mey N; van der Meulen J; Niemeyer MG Int J Clin Pharmacol Ther; 1996 Jul; 34(7):312-7. PubMed ID: 8832309 [TBL] [Abstract][Full Text] [Related]
2. Quality of life before and during antihypertensive treatment: a comparative study of celiprolol and atenolol. Cleophas TJ; vd Mey N; Meulen J; Niemeyer MG Am J Ther; 1997 Apr; 4(4):117-22. PubMed ID: 10423600 [TBL] [Abstract][Full Text] [Related]
3. Quality of life perception during antihypertensive treatment: a comparative study of bisoprolol and enalapril. Breed JG; Ciampricotti R; Tromp GP; Valster FA; Lageweg E; Van Bortel LM J Cardiovasc Pharmacol; 1992; 20(5):750-5. PubMed ID: 1280737 [TBL] [Abstract][Full Text] [Related]
4. Different hemodynamic effects of celipropol and atenolol in patients with mild to moderate hypertension. Saner H; Seiler A; Mahler F Arzneimittelforschung; 1995 Jul; 45(7):790-5. PubMed ID: 8573224 [TBL] [Abstract][Full Text] [Related]
5. Randomized controlled trial of ACE-inhibitors and beta-blockers with and without vasodilating activity in chronic glomerulonephritis. Erley CM; Klass M; Krämer D; Berger E; Heyne N; Braun N; Wolf S; Risler T Int J Clin Pharmacol Ther; 1996 Nov; 34(11):504-9. PubMed ID: 8937934 [TBL] [Abstract][Full Text] [Related]
6. A randomized controlled trial of the effects of three antihypertensive agents on blood pressure control and quality of life in older women. Applegate WB; Phillips HL; Schnaper H; Shepherd AM; Schocken D; Luhr JC; Koch GG; Park GD Arch Intern Med; 1991 Sep; 151(9):1817-23. PubMed ID: 1888248 [TBL] [Abstract][Full Text] [Related]
7. A 16-week, randomized, double-blind, placebo-controlled, crossover trial to quantify the combined effect of an angiotensin-converting enzyme inhibitor and a beta-blocker on blood pressure reduction. Wald DS; Law M; Mills S; Bestwick JP; Morris JK; Wald NJ Clin Ther; 2008 Nov; 30(11):2030-9. PubMed ID: 19108791 [TBL] [Abstract][Full Text] [Related]
8. Swedish Isradipine Study in Hypertension: evaluation of quality of life, safety, and efficacy. SWISH Group. Jern S; Hansson L; Scherstén B; Kullman S; Sörensen S; Dahlöf B; Eggertsen R; Sivertsson R J Cardiovasc Pharmacol; 1991; 18 Suppl 3():S7-8. PubMed ID: 1720487 [TBL] [Abstract][Full Text] [Related]
9. Impact of the treatment of isolated systolic hypertension on behavioral variables. Results from the systolic hypertension in the elderly program. Applegate WB; Pressel S; Wittes J; Luhr J; Shekelle RB; Camel GH; Greenlick MR; Hadley E; Moye L; Perry HM Arch Intern Med; 1994 Oct; 154(19):2154-60. PubMed ID: 7944835 [TBL] [Abstract][Full Text] [Related]
10. Twenty-four-hour ambulatory blood pressure monitoring efficacy of perindopril/indapamide first-line combination in hypertensive patients: the REASON study. Mallion JM; Chamontin B; Asmar R; De Leeuw PW; O'Brien E; Duprez D; O'Rourke MF; Rahn KH; Romero R; Battegay E; Hitzenberger G; Safar ME; Am J Hypertens; 2004 Mar; 17(3):245-51. PubMed ID: 15001199 [TBL] [Abstract][Full Text] [Related]
11. Blood pressure reduction and antihypertensive medication use in the losartan intervention for endpoint reduction in hypertension (LIFE) study in patients with hypertension and left ventricular hypertrophy. Devereux RB; de Faire U; Fyhrquist F; Harris KE; Ibsen H; Kjeldsen SE; Lederballe-Pedersen O; Lindholm LH; Nieminen MS; Omvik P; Oparil S; Wedel H; Hille DA; Dahlöf B Curr Med Res Opin; 2007 Feb; 23(2):259-70. PubMed ID: 17288679 [TBL] [Abstract][Full Text] [Related]
12. Results of a phase III, 8-week, multicenter, prospective, randomized, double-blind, parallel-group clinical trial to assess the effects of amlodipine camsylate versus amlodipine besylate in Korean adults with mild to moderate hypertension. Kim SH; Kim YD; Lim DS; Yoon MH; Ahn YK; On YK; Lee JW; Kim IJ; Park JB; Kim JJ; Chung WS; Yang JY; Seo HS; Shin EK; Kim HS; Clin Ther; 2007 Sep; 29(9):1924-36. PubMed ID: 18035192 [TBL] [Abstract][Full Text] [Related]
13. Antihypertensive therapy and quality of life: a comparison of atenolol, captopril, enalapril and propranolol. Steiner SS; Friedhoff AJ; Wilson BL; Wecker JR; Santo JP J Hum Hypertens; 1990 Jun; 4(3):217-25. PubMed ID: 2194029 [TBL] [Abstract][Full Text] [Related]
14. The Losartan Intervention For Endpoint reduction (LIFE) in Hypertension study: rationale, design, and methods. The LIFE Study Group. Dahlöf B; Devereux R; de Faire U; Fyhrquist F; Hedner T; Ibsen H; Julius S; Kjeldsen S; Kristianson K; Lederballe-Pedersen O; Lindholm LH; Nieminen MS; Omvik P; Oparil S; Wedel H Am J Hypertens; 1997 Jul; 10(7 Pt 1):705-13. PubMed ID: 9234823 [TBL] [Abstract][Full Text] [Related]
15. The neglected time factor and antihypertensive therapy. A pitfall in evaluating side effects in a cross-over study. Edmonds D; Greminger P; Vetter W; Baumgart P; Vetter H Postgrad Med; 1988 Feb; Spec No():40-5. PubMed ID: 2831525 [TBL] [Abstract][Full Text] [Related]
16. [Safety and efficacy of celiprolol in hypertensive patients with chronic obstructive lung disease]. Chahuán M; Corradi L; Román O; Bravo C Rev Med Chil; 2000 Jan; 128(1):59-63. PubMed ID: 10883523 [TBL] [Abstract][Full Text] [Related]
17. Prazosin GITS vs atenolol in patients with hypertension and normal lipid profile: a randomized, controlled multicenter study. Hyderabad Hypertension Study Group. Joglekar SJ; Jaguste V; Nanivadekar AS J Assoc Physicians India; 1998; Suppl 1():41-51. PubMed ID: 11233386 [TBL] [Abstract][Full Text] [Related]
18. Comparison of respiratory effects of two cardioselective beta-blockers, celiprolol and atenolol, in asthmatics with mild to moderate hypertension. van Zyl AI; Jennings AA; Bateman ED; Opie LH Chest; 1989 Jan; 95(1):209-13. PubMed ID: 2562825 [TBL] [Abstract][Full Text] [Related]
19. Efficacy and tolerability of combination therapy with valsartan plus hydrochlorothiazide compared with amlodipine monotherapy in hypertensive patients with other cardiovascular risk factors: the VAST study. Ruilope LM; Malacco E; Khder Y; Kandra A; Bönner G; Heintz D Clin Ther; 2005 May; 27(5):578-87. PubMed ID: 15978306 [TBL] [Abstract][Full Text] [Related]
20. Efficacy and tolerability profile of nebivolol vs atenolol in mild-to-moderate essential hypertension: results of a double-blind randomized multicentre trial. Grassi G; Trevano FQ; Facchini A; Toutouzas T; Chanu B; Mancia G Blood Press Suppl; 2003 Dec; 2():35-40. PubMed ID: 14761075 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]